Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children

NACompletedINTERVENTIONAL
Enrollment

423

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Lifestyle-related ConditionOverweight and ObesityEssential Fatty Acid Deficiency
Interventions
DIETARY_SUPPLEMENT

Omega-3

This group will receive capsules containing omega-3, omega-6 and vitamin E. The dosage is six capsules per day containing a total of 558 mg of eico-pentaenoic acid (EPA), 174 mg of docosahexaeonic acid (DHA), 60 mg of gamma-linolenic acid (GLA) and 9,6 mg vitamin E in natural form (alfa-tocopherol), gelatine, glycerol. Participants will be instructed to eat three capsules each morning and evening.

DIETARY_SUPPLEMENT

Placebo

This group will receive capsules containing rape seed oil. Participants will be instructed to eat three capsules each morning and evening.

Trial Locations (1)

14186

Karolinska Universitetssjukhuset, Huddinge

All Listed Sponsors
collaborator

Midsona AB

UNKNOWN

collaborator

Forskningsrådet för arbetsliv och socialvetenskap, FAS

UNKNOWN

lead

Karolinska Institutet

OTHER

NCT01323283 - Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children | Biotech Hunter | Biotech Hunter